Автор туралы ақпарат

Grechukhina, K. S

Шығарылым	Бөлім	Атауы	Файл
Том 28, № 7 (2021)	Articles	Abemacyclib is a unique representative of the class of CDK4/6 inhibitors in the treatment of HR+/HER2- metastatic breast cancer
Том 28, № 11 (2021)	Articles	Dual HER2 blockade with pertuzumab+trastuzumab on the eve of a new era in the treatment of HER2-positive breast cancer

TOP